LMGAM
IART icon

Liberty Mutual Group Asset Management’s Integra LifeSciences IART Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,047
Closed -$925K – 377
2018
Q3 		$925K Hold
14,047
– – 0.02% 420
2018
Q2 		$905K Buy
+14,047
New +$870K 0.02% 426

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Liberty Mutual Group Asset Management's IART Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of Integra LifeSciences (IART) in Q4 2018, closing a stake of 14,047 shares — an estimated $925K sold.

Liberty Mutual Group Asset Management first reported a position in IART in Q2 2018 and held it in 2 quarters. The position peaked at $925K in Q3 2018. 248 funds tracked by Wall St. Rank hold IART as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining Integra LifeSciences position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 14,047 Integra LifeSciences shares in Q4 2018, an estimated $925K.
  • Liberty Mutual Group Asset Management first reported a position in Integra LifeSciences in Q2 2018 and held it in 2 quarters.
  • Liberty Mutual Group Asset Management's Integra LifeSciences position peaked at $925K in Q3 2018.
  • 248 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.